These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tocainide. A review of its pharmacological properties and therapeutic efficacy. Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1983 Aug; 26(2):93-123. PubMed ID: 6411445 [TBL] [Abstract][Full Text] [Related]
4. Lignocaine therapy after acute myocardial infarction. Chopra MP; Portal RW; Aber CP Br Med J; 1969 Jan; 1(5638):213-6. PubMed ID: 5762622 [TBL] [Abstract][Full Text] [Related]
5. Logical approach to lignocaine therapy. Aps C; Bell JA; Jenkins BS; Poole-Wilson PA; Reynolds F Br Med J; 1976 Jan; 1(6000):13-5. PubMed ID: 1247716 [TBL] [Abstract][Full Text] [Related]
6. Impaired absorption and metabolism of oral lignocaine in patients undergoing laparoscopy. Adjepon-Yamoah KK; Scott DB; Prescott LF Br J Anaesth; 1973 Feb; 45(2):143-7. PubMed ID: 4267409 [No Abstract] [Full Text] [Related]
7. Lignocaine for acute ventricular arrhythmias. Drug Ther Bull; 1969 Jan; 7(2):5-6. PubMed ID: 5763260 [No Abstract] [Full Text] [Related]
8. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction. Rønnevik PK; Gundersen T; Abrahamsen AM Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic basis for the treatment of cardiac arrhythmias. Gelband H; Rosen MR Pediatrics; 1975 Jan; 55(1):59-67. PubMed ID: 1089243 [No Abstract] [Full Text] [Related]
10. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias. Chew CY; Collett J; Singh BN Drugs; 1979 Mar; 17(3):161-81. PubMed ID: 378646 [TBL] [Abstract][Full Text] [Related]
11. Tocainide: a new drug for ventricular arrhythmias. Volosin KJ; Greenspon AJ Am Fam Physician; 1986 Jan; 33(1):233-5. PubMed ID: 3079938 [No Abstract] [Full Text] [Related]
12. Clinical pharmacokinetics of lignocaine. Benowitz NL; Meister W Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470 [TBL] [Abstract][Full Text] [Related]
13. Changes in lignocaine disposition during long-term infusion in patients with acute ventricular arrhythmias. Thomson AH; Kelman AW; de Vane PJ; Hillis WS; Whiting B Ther Drug Monit; 1987 Sep; 9(3):283-91. PubMed ID: 3672571 [TBL] [Abstract][Full Text] [Related]
14. [Lignocaine in the treatment of arrhythmia]. Gürtler-Krawczyńska E Wiad Lek; 1971 Jun; 24(12):1205-9. PubMed ID: 5561278 [No Abstract] [Full Text] [Related]
15. Prediction of individual dosage requirements for lignocaine: a validation study for Bayesian forecasting in Japanese patients. Uematsu T; Hirayama H; Nagashima S; Yamazaki T; Tsuchiya N; Sato R; Nakashima M Ther Drug Monit; 1989; 11(1):25-31. PubMed ID: 2911849 [TBL] [Abstract][Full Text] [Related]
16. [LETTER: Lidocaine per os. Its value in ventricular rhythm disorders]. Lekieffre J; Thery C; Ginestet A; Carré A; Warembourg H Nouv Presse Med; 1975 Jan; 4(3):188-9. PubMed ID: 1129077 [No Abstract] [Full Text] [Related]
17. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables. Fredrick DS; Boersma RB Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893 [TBL] [Abstract][Full Text] [Related]
18. Comparative local anaesthetic and antiarrhythmic actions of levamisole hydrochloride and lignocaine hydrochloride. Onuaguluchi G; Igbo IN Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):278-89. PubMed ID: 3426349 [TBL] [Abstract][Full Text] [Related]
19. The effect of atropine on the oral absorption of lidocaine in man. Adjepon-Yamoah KK; Scott DB; Prescott LF Eur J Clin Pharmacol; 1974 Aug; 7(5):397-400. PubMed ID: 4278602 [No Abstract] [Full Text] [Related]
20. The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man. Thomson PD; Rowland M; Melmon KL Am Heart J; 1971 Sep; 82(3):417-21. PubMed ID: 5565429 [No Abstract] [Full Text] [Related] [Next] [New Search]